Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Huachen Pharmaceutical Group Co., Ltd. is a modern pharmaceutical enterprise established in 1991 and headquartered in Huanghua, Cangzhou City, Hebei Province, China. The company integrates the research and development, production, and sales of active pharmaceutical ingredients (APIs), finished preparations, pharmaceutical packaging materials, and medical devices. Its extensive API portfolio includes medicinal sodium chloride, sodium bicarbonate, potassium chloride, calcium chloride, lidocaine, and oseltamivir phosphate, meeting international standards such as BP, USP, and JP. Huachen Pharmaceutical Group operates multiple GMP-compliant production lines for various dosage forms, including tablets, hard capsules, granules, powders, ointments, gel patches, and oral liquids, serving both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 河北华晨药业集团.